Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07279844
An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease
Sponsor: Anhui Provincial Hospital
View on ClinicalTrials.gov
Summary
To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years
Key Details
Gender
All
Age Range
45 Years - 70 Years
Study Type
OBSERVATIONAL
Enrollment
6
Start Date
2025-12-15
Completion Date
2029-12-14
Last Updated
2025-12-12
Healthy Volunteers
No
Conditions
Interventions
OTHER
Observational
Long-term observational